Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D07VXX
|
|||
Former ID |
DNC007392
|
|||
Drug Name |
2-(benzyloxyamino)-N-hydroxy-3-methylpentanamide
|
|||
Synonyms |
CHEMBL228231; 2-(benzyloxyamino)-N-hydroxy-3-methylpentanamide
Click to Show/Hide
|
|||
Drug Type |
Small molecular drug
|
|||
Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
Structure |
Download2D MOL |
|||
Formula |
C13H20N2O3
|
|||
Canonical SMILES |
CCC(C)C(C(=O)NO)NOCC1=CC=CC=C1
|
|||
InChI |
1S/C13H20N2O3/c1-3-10(2)12(13(16)14-17)15-18-9-11-7-5-4-6-8-11/h4-8,10,12,15,17H,3,9H2,1-2H3,(H,14,16)
|
|||
InChIKey |
OISVGEVVTLNTBZ-UHFFFAOYSA-N
|
|||
PubChem Compound ID |
Target and Pathway | Top | |||
---|---|---|---|---|
Target(s) | Carbonic anhydrase IX (CA-IX) | Target Info | Inhibitor | [1] |
KEGG Pathway | Nitrogen metabolism | |||
Pathway Interaction Database | HIF-1-alpha transcription factor network | |||
Reactome | Regulation of gene expression by Hypoxia-inducible Factor | |||
Reversible hydration of carbon dioxide | ||||
WikiPathways | Vitamin D Receptor Pathway | |||
Reversible Hydration of Carbon Dioxide | ||||
Regulation of Hypoxia-inducible Factor (HIF) by Oxygen |
References | Top | |||
---|---|---|---|---|
REF 1 | Carbonic anhydrase and matrix metalloproteinase inhibitors. Inhibition of human tumor-associated isozymes IX and cytosolic isozyme I and II with su... Bioorg Med Chem. 2007 Mar 15;15(6):2298-311. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.